Ultragenyx Pharmaceutical (RARE) Change in Receivables (2018 - 2026)
Ultragenyx Pharmaceutical (RARE) recorded Change in Receivables of $62 million in Q2 2026, up 376.9% from $13 million a year earlier.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Change in Receivables (2018 - 2026) Analysis & Trends
On a TTM basis, Ultragenyx Pharmaceutical's Change in Receivables came in at $71 million as of Jun 30, 2026, up 398.2% year-over-year; for FY2025, it was $31 million, down 8.8% from FY2024.
- Across earlier years, Change in Receivables came in at $34 million in FY2024 (+47.8%), $23 million in FY2023 (+90.6%), $12.07 million in FY2022 (+122.2%) and $5.43 million in FY2021.
- The Q2 2026 figure is the highest quarterly Change in Receivables in data going back to Q1 2018.
- Per Business Quant, the preceding three quarters came in at -$19 million (Q1 2026), $33.83 million (Q4 2025) and -$5.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | 62.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.00 Mn |
| Mar 31, 2026 | -19.00 Mn |
| Dec 31, 2025 | 33.83 Mn |
| Sep 30, 2025 | -5.83 Mn |
| Jun 30, 2025 | 13.00 Mn |
| Mar 31, 2025 | -10.00 Mn |
| Dec 31, 2024 | 21.04 Mn |
| Sep 30, 2024 | -9.79 Mn |
| Jun 30, 2024 | -2.16 Mn |
| Mar 31, 2024 | 24.91 Mn |
| Dec 31, 2023 | -790,000.00 |
| Sep 30, 2023 | 6.20 Mn |
| Jun 30, 2023 | 15.08 Mn |
| Mar 31, 2023 | 2.51 Mn |
| Dec 31, 2022 | 9.10 Mn |
| Sep 30, 2022 | -5.93 Mn |
| Jun 30, 2022 | 8.94 Mn |
| Mar 31, 2022 | -33,000.00 |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | 693,000.00 |
API Access
Ultragenyx Pharmaceutical Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();